vimarsana.com

Stanford University Interdepartmental Program In Immunology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple SclerosisMonday, March 14th @ 11 am ET, registration details below

Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple SclerosisMonday, March 14th @ 11 am ET, registration details below - read this article along with other careers information, tips and advice on BioSpace

United statesIrina kofflerLawrence steinmanNeuromyelitis opticaRobertl krocHowardl weinerTarun singhalHoward weinerHana malikTanuja chitnisBrigham pediatric ms centerProfessor of neurology at harvard medical schoolImaging program in neurologic diseasesFounder of the partners multiple sclerosis centerStanford university interdepartmental program in immunologyNeurological sciences

Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple Sclerosis

Tiziana Life Sciences Ltd (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, announced today that it will host a virtual Key Opinion Leader (KOL) webinar event, “Foralumab Clinical Update in Multiple Sclerosis: A Landmark .

United statesIrina kofflerLawrence steinmanNeuromyelitis opticaRobertl krocHowardl weinerTarun singhalHoward weinerHana malikTanuja chitnisBrigham pediatric ms centerProfessor of neurology at harvard medical schoolImaging program in neurologic diseasesTiziana life sciences ltd nasdaqFounder of the partners multiple sclerosis centerStanford university interdepartmental program in immunology

Tiziana Life Sciences Ltd : Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple Sclerosis

Monday, March 14th @ 11 am ET, registration details belowNEW YORK, March 11, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling

United statesIrina kofflerLawrence steinmanNeuromyelitis opticaRobertl krocHowardl weinerTarun singhalHoward weinerHana malikTanuja chitnisBrigham pediatric ms centerProfessor of neurology at harvard medical schoolImaging program in neurologic diseasesTiziana life sciences ltd nasdaqFounder of the partners multiple sclerosis centerStanford university interdepartmental program in immunology

Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple Sclerosis

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesIrina kofflerLawrence steinmanNeuromyelitis opticaRobertl krocHowardl weinerTarun singhalHoward weinerHana malikTanuja chitnisBrigham pediatric ms centerProfessor of neurology at harvard medical schoolImaging program in neurologic diseasesTiziana life sciences ltd nasdaqFounder of the partners multiple sclerosis centerStanford university interdepartmental program in immunology

vimarsana © 2020. All Rights Reserved.